Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent Chen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Drug Targeting|May 5, 2016
PRCosomes: pretty reactive complexes formed in liposomesMohamed Wehbe, Lina Chernov, Kent Chen, et al.
Plos One|April 8, 2016
Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical DevelopmentMohamed Wehbe, Malathi Anantha, Ian Backstrom, et al.
Journal of Molecular and Cellular Cardiology|August 18, 2009
Cell therapy enhances function of remote non-infarcted myocardiumAlicia Moreno-Gonzalez, F Steven Korte, Jin Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
<i>In Vivo</i> Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic TargetAda W Y Leung, Chansey J Veinotte, Nicole Melong, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Drug Targeting|May 5, 2016
PRCosomes: pretty reactive complexes formed in liposomesMohamed Wehbe, Lina Chernov, Kent Chen, et al.
Plos One|April 8, 2016
Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical DevelopmentMohamed Wehbe, Malathi Anantha, Ian Backstrom, et al.
Journal of Molecular and Cellular Cardiology|August 18, 2009
Cell therapy enhances function of remote non-infarcted myocardiumAlicia Moreno-Gonzalez, F Steven Korte, Jin Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2017
<i>In Vivo</i> Validation of PAPSS1 (3'-phosphoadenosine 5'-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic TargetAda W Y Leung, Chansey J Veinotte, Nicole Melong, et al.
Pageof 1